Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2019 Filed Apr 3, 2019 18:44 UTC |
CONRADES GEORGE HDirector
|
GrantCommon Stock | 2,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023461 · doc4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,421 F1 · kind: Represents a restricted stock award that vests as to 100% of the shares of Common Stock on May 30, 2019, subject to the director's continuing service to the Company through the vesting date. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 01:14 UTC |
MCGUIRE TERRANCEDirector
|
GrantCommon Stock | 6,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023566 · doc4.xml · nonDerivative · entry 4 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Bartlett Partners, L.L.C. Disclosed balance after: 6,911 F3 · shares: Represents shares of Cyclerion common stock acquired as a result of adjustments to existing Ironwood shares of common stock made in connection with the Separation. F5 · ownership.nature: The reporting person is a managing member of Bartlett Partners, LLC, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the securities, except to the extent of his pecuniary interest therein. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 01:14 UTC |
MCGUIRE TERRANCEDirector
|
GrantCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023566 · doc4.xml · nonDerivative · entry 3 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Polaris Venture Management Co. II, L.L.C. Disclosed balance after: 162 F3 · shares: Represents shares of Cyclerion common stock acquired as a result of adjustments to existing Ironwood shares of common stock made in connection with the Separation. F4 · ownership.nature: The reporting person is a managing member of Polaris Venture Management Co. II, L.L.C., the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 01:14 UTC |
MCGUIRE TERRANCEDirector
|
GrantCommon Stock | 3,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023566 · doc4.xml · nonDerivative · entry 2 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,279 F2 · shares: Represents shares of Cyclerion common stock granted to the reporting person as a result of adjustments to existing Ironwood shares of common stock made in connection with the Separation. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 01:14 UTC |
MCGUIRE TERRANCEDirector
|
GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023566 · doc4.xml · nonDerivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,768 F1 · shares: In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received Cyclerion shares representing an equitable adjustment of Ironwood shares held by the reporting person prior to the Separation. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 857,977 | $0.00 Strike: $14.20 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · derivative · entry 15 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 857,977 Underlying: Common Stock · 857,977 shares Expires 2029-01-29 F3 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F9 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of common stock on each monthly anniversary of January 1, 2019. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 380,393 | $0.00 Strike: $16.02 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · derivative · entry 14 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,393 Underlying: Common Stock · 380,393 shares Expires 2028-02-21 F3 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F8 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of common stock on each monthly anniversary of January 1, 2018. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 344,829 | $0.00 Strike: $18.46 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · derivative · entry 13 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,829 Underlying: Common Stock · 344,829 shares Expires 2027-02-27 F3 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F7 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of common stock on each monthly anniversary of January 1, 2017. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 223,919 | $0.00 Strike: $11.28 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · derivative · entry 12 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,919 Underlying: Common Stock · 223,919 shares Expires 2026-03-01 F3 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F6 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of common stock on each monthly anniversary of January 1, 2016. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 56,500 | $0.00 Strike: $17.20 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · derivative · entry 11 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,500 Underlying: Common Stock · 56,500 shares Expires 2025-03-16 F3 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F5 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 37,973 | $0.00 Strike: $15.54 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · derivative · entry 10 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,973 Underlying: Common Stock · 37,973 shares Expires 2024-03-03 F3 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F5 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 43,680 | $0.00 Strike: $14.40 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · derivative · entry 9 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,680 Underlying: Common Stock · 43,680 shares Expires 2023-02-01 F3 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F5 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 36,089 | $0.00 Strike: $16.21 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · derivative · entry 8 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,089 Underlying: Common Stock · 36,089 shares Expires 2022-02-01 F3 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F5 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 53,090 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · derivative · entry 7 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,090 Underlying: Common Stock · 53,090 shares Expires 2021-02-01 F3 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F5 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 12,499 | $0.00 Strike: $12.39 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · derivative · entry 6 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,499 Underlying: Common Stock · 12,499 shares Expires 2020-02-02 F3 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F5 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · derivative · entry 5 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2019-07-28 F3 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F4 · derivative.exercise_date: This option to purchase 20,170 shares vests in installments upon achievement of certain regulatory and commercial milestones. The option has vested as to 2,000 shares as of the date hereof. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantCommon Stock | 485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · nonDerivative · entry 4 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · The 2000 Trust for Zoe Niovi Hecht Disclosed balance after: 485 F2 · shares: These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose. F2 · ownership.nature: These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantCommon Stock | 485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · nonDerivative · entry 3 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · The 2000 Trust for Malcolm Paul Hecht Disclosed balance after: 485 F2 · shares: These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose. F2 · ownership.nature: These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantCommon Stock | 485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · nonDerivative · entry 2 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · The 2000 Trust for Alexis Mae Hecht Disclosed balance after: 485 F2 · shares: These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose. F2 · ownership.nature: These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantCommon Stock | 223,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023556 · doc4.xml · nonDerivative · entry 1 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,192 F1 · shares: In Connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received Cyclerion shares representing an equitable adjustment of Ironwood shares held by the reporting person prior to the separation. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 514,786 | $0.00 Strike: $14.20 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · derivative · entry 13 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,786 Underlying: Common Stock · 514,786 shares Expires 2029-01-29 F2 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F8 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2019. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 141,007 | $0.00 Strike: $16.02 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · derivative · entry 12 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,007 Underlying: Common Stock · 141,007 shares Expires 2028-02-21 F2 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F7 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2018. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 113,430 | $0.00 Strike: $18.46 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · derivative · entry 11 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,430 Underlying: Common Stock · 113,430 shares Expires 2027-02-27 F2 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F6 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2017. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,801 | $0.00 Strike: $11.28 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · derivative · entry 10 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,801 Underlying: Common Stock · 50,801 shares Expires 2026-03-01 F2 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F5 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2016. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $17.20 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · derivative · entry 9 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2025-03-16 F2 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F4 · derivative.exercise_date: This option to purchase 25,212 shares vests in equal installments upon achievement of certain regulatory and commercial milestones. The option has vested as to 2,500 shares as of the date hereof. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 13,125 | $0.00 Strike: $17.20 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · derivative · entry 8 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2025-03-16 F2 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F3 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,930 | $0.00 Strike: $15.54 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · derivative · entry 7 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,930 Underlying: Common Stock · 9,930 shares Expires 2024-03-03 F2 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F3 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 27,773 | $0.00 Strike: $14.40 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · derivative · entry 6 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,773 Underlying: Common Stock · 27,773 shares Expires 2023-02-01 F2 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F3 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,491 | $0.00 Strike: $16.21 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · derivative · entry 5 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,491 Underlying: Common Stock · 17,491 shares Expires 2022-02-01 F2 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F3 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 37,286 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · derivative · entry 4 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,286 Underlying: Common Stock · 37,286 shares Expires 2021-02-01 F2 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F3 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 888 | $0.00 Strike: $12.39 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · derivative · entry 3 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888 Underlying: Common Stock · 888 shares Expires 2020-02-02 F2 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F3 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
GrantCommon Stock | 51,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · nonDerivative · entry 1 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,648 F1 · shares: In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received Cyclerion shares representing an equitable adjustment of Ironwood shares held by the reporting person prior to the Separation. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:34 UTC |
SCHULMAN AMY WDirector
|
GrantCommon Stock | 3,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023514 · doc4.xml · nonDerivative · entry 2 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,508 F2 · shares: Represents shares of Cyclerion common stock granted to the reporting person as a result of adjustments to existing Ironwood shares of common stock made in connection with the Separation. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:34 UTC |
SCHULMAN AMY WDirector
|
GrantCommon Stock | 4,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023514 · doc4.xml · nonDerivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,229 F1 · shares: In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received Cyclerion shares representing an equitable adjustment of Ironwood shares held by the reporting person prior to the Separation. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:08 UTC Amendment |
Fanucci MarshaDirector
|
GrantCommon Stock | 3,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023565 · doc4a.xml · nonDerivative · entry 2 Fanucci Marsha · CIK 0001298814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,950 F2 · shares: Represents shares of Cyclerion common stock granted to the reporting person as a result of adjustments to existing Ironwood shares of common stock made in connection with the Separation. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:08 UTC Amendment |
Fanucci MarshaDirector
|
GrantCommon Stock | 13,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023565 · doc4a.xml · nonDerivative · entry 1 Fanucci Marsha · CIK 0001298814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,671 F1 · shares: In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received Cyclerion shares representing an equitable adjustment of Ironwood shares held by the reporting person prior to the Separation. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 19:32 UTC |
Fanucci MarshaDirector
|
GrantCommon Stock | 3,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023507 · doc4.xml · nonDerivative · entry 2 Fanucci Marsha · CIK 0001298814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,950 F2 · shares: Represents shares of Cyclerion common stock granted to the reporting person as a result of adjustments to existing Ironwood shares of common stock made in connection with the Separation. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 19:32 UTC |
Fanucci MarshaDirector
|
GrantCommon Stock | 13,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023507 · doc4.xml · nonDerivative · entry 1 Fanucci Marsha · CIK 0001298814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,671 F1 · shares: In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received Cyclerion shares representing an equitable adjustment of Ironwood shares held by the reporting person prior to the Separation. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:23 UTC |
Mendelsohn MichaelDirector
|
GrantCommon Stock | 2,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023494 · doc4.xml · nonDerivative · entry 1 Mendelsohn Michael · CIK 0001591109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,421 F1 · kind: Represents a restricted stock award that vests as to 100% of the shares of Common Stock on May 30, 2019, subject to the director's continuing service to the Company through the vesting date. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 19:39 UTC |
Huyett WilliamChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 222,002 | $0.00 Strike: $14.20 | $0.00 |
DisclosureSEC source: 0001209191-19-023517 · doc4.xml · derivative · entry 4 Huyett William · CIK 0001723846 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,002 Underlying: Common Stock · 222,002 shares Expires 2029-01-29 F4 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F6 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of common stock on each monthly anniversary of January 1, 2019. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 19:39 UTC |
Huyett WilliamChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 221,349 | $0.00 Strike: $16.81 | $0.00 |
DisclosureSEC source: 0001209191-19-023517 · doc4.xml · derivative · entry 3 Huyett William · CIK 0001723846 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,349 Underlying: Common Stock · 221,349 shares Expires 2028-01-02 F4 · derivative.exercise_price: Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. F5 · derivative.exercise_date: The option, granted as a new hire award, vested as to 25% of the shares of common stock on December 15, 2019, and 2.08333% of the shares of common stock vest each month thereafter for the next 36 months. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 19:39 UTC |
Huyett WilliamChief Financial Officer
|
GrantCommon Stock | 39,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023517 · doc4.xml · nonDerivative · entry 2 Huyett William · CIK 0001723846 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,912 F2 · shares: In connection with the Separation, the reporting person received a grant of 39,179 restricted stock units, each representing the right to receive a share of Cyclerion common stock, as a result of the adjustment of existing Ironwood restricted stock units held by the reporting person prior to the Separation. The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of common stock on the approximate anniversary of the grant. F3 · balance_after: Includes 1,406 shares of Cyclerion common stock received in a pro rata distribution by Ironwood as a result of the Separation. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 19:39 UTC |
Huyett WilliamChief Financial Officer
|
GrantCommon Stock | 38,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023517 · doc4.xml · nonDerivative · entry 1 Huyett William · CIK 0001723846 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,327 F1 · shares: In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals Inc. ("Ironwood"), the reporting person received a grant of 38,327 restricted stock units, each representing the right to receive a share of Cyclerion common stock, as a result of the adjustment of existing Ironwood restricted stock units held by the reporting person prior to the Separation. The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of common stock on the approximate anniversary of the grant. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:21 UTC |
Lovell StephanieDirector
|
GrantCommon Stock | 2,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023488 · doc4.xml · nonDerivative · entry 1 Lovell Stephanie · CIK 0001772054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,421 F1 · kind: Represents a restricted stock award that vests as to 100% of the shares of Common Stock on May 30, 2019, subject to the director's continuing service to the Company through the vesting date. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:17 UTC |
Isacson OleDirector
|
GrantCommon Stock | 2,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023486 · doc4.xml · nonDerivative · entry 1 Isacson Ole · CIK 0001772001 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,421 F1 · kind: Represents a restricted stock award that vests as to 100% of the shares of Common Stock on May 30, 2019, subject to the director's continuing service to the Company through the vesting date. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:43 UTC |
Churchwell KevinDirector
|
GrantCommon Stock | 2,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023381 · doc4.xml · nonDerivative · entry 1 Churchwell Kevin · CIK 0001771984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,421 F1 · kind: Represents a restricted stock award that vests as to 100% of the shares of common stock on May 30, 2019, subject to the director's continuing service to the Company through the Vesting Date. F1 · shares: Represents a restricted stock award that vests as to 100% of the shares of common stock on May 30, 2019, subject to the director's continuing service to the Company through the Vesting Date. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 18:25 UTC Amendment |
CONRADES GEORGE HDirector
|
GrantCommon Stock | 2,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023727 · doc4a.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,334 F1 · kind: Represents a restricted stock award that vests as to 100% of the shares of Common Stock on May 30, 2019, subject to the director's continuing service to the Company through the vesting date. F2 · balance_after: Includes 1,913 shares of Cyclerion Therapeutics, Inc. common stock received in a pro rata distribution by Ironwood Pharmaceuticals, Inc. as a result of the separation. Read SEC document |
| April 01, 2019 Filed Sep 20, 2019 20:05 UTC Amendment |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 857,830 | $0.00 Strike: $14.21 | $0.00 |
DisclosureSEC source: 0001209191-19-050311 · doc4a.xml · derivative · entry 9 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 857,830 Underlying: Common Stock · 857,830 shares Expires 2029-01-29 F2 · derivative.exercise_price: This report has been amended to correct the exercise price of the stock options that were originally issued by Ironwood in connection with the Separation. F8 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2019. F4 · balance_after: This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation. Read SEC document |
| April 01, 2019 Filed Sep 20, 2019 20:05 UTC Amendment |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 380,330 | $0.00 Strike: $16.02 | $0.00 |
DisclosureSEC source: 0001209191-19-050311 · doc4a.xml · derivative · entry 8 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,330 Underlying: Common Stock · 380,330 shares Expires 2028-02-21 F7 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2018. F4 · balance_after: This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation. Read SEC document |
| April 01, 2019 Filed Sep 20, 2019 20:05 UTC Amendment |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 344,777 | $0.00 Strike: $18.47 | $0.00 |
DisclosureSEC source: 0001209191-19-050311 · doc4a.xml · derivative · entry 7 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,777 Underlying: Common Stock · 344,777 shares Expires 2027-02-27 F2 · derivative.exercise_price: This report has been amended to correct the exercise price of the stock options that were originally issued by Ironwood in connection with the Separation. F6 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2017. F4 · balance_after: This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.